Patrick focused on neuropharmacology research in academia/industry, both in France and US (1986-1990) then Synthélabo Recherche in 1991. At Synthélabo group, Sanofi-Synthélabo and Sanofi-Aventis he developed external public financing, collaborative R&D program and a team managing up to 40 collaborations in Europe (1996-2007). After 2007 he developed global scouting & partnering for innovation, Bioclusters and IMI integration for Sanofi as well as strategy for Bio Business conventions in Europe, Asia and US.
Since 2014 he serves as CEO of Nanobiotix Corp, Nanobiotix US affiliate.
Patrick is PharmD, Master in Pharmacology & Pharmacokinetic and EMBA from ESCP Europe.